| Code | CSB-MP021335HUd7 |
| Abbreviation | Recombinant Human SIRPB1 protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
SIRPB1 functions as an immunomodulatory receptor on myeloid and lymphoid cells, and this mammalian-expressed extracellular domain (aa 30–371) preserves the native glycosylation and disulfide architecture required for physiologically relevant antibody recognition. Functional ELISA demonstrates dose-dependent binding to an anti-SIRPB1 recombinant antibody with an EC50 of 0.97–1.11 ng/mL, while surface plasmon resonance confirms high-affinity interaction at a KD of 0.245 nM, providing quantitative benchmarks for therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation in immune checkpoint research. The dual-method purity confirmation (>95% by SDS-PAGE and SEC-HPLC) combined with endotoxin levels below 1.0 EU/μg aligns with standards expected in ligand-binding assays, SPR-based affinity characterization, and biolayer interferometry studies where contaminant interference must be minimized. This partial construct serves as a positive control in receptor-ligand interaction platforms and supports drug discovery workflows targeting SIRP family members in cancer immunotherapy.
There are currently no reviews for this product.